サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1675435

心臓ペースメーカー市場：タイプ別、技術別、適応症別、エンドユーザー別、地域別、2025-2033年

Cardiac Pacemaker Market by Type, Technology, Indication, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 147 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
心臓ペースメーカー市場：タイプ別、技術別、適応症別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年03月01日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心臓ペースメーカー市場の世界市場規模は2024年に52億米ドルに達しました。今後、IMARC Groupは、2033年には70億米ドルに達し、2025～2033年の成長率（CAGR）は3.29％になると予測しています。CVDの有病率の増加、健康保険加入者の増加、手術技術向上のための広範な研究開発（R&D）が市場を牽引する主な要因です。

心臓ペースメーカーは、電気パルスを利用して心臓のリズム障害を治療するために胸部や腹部に埋め込む小型の医療機器であり、心拍の調節や監視を補助します。マイクロプロセッサー、センサー、電極、ワイヤー、リード線、ハウジングなどの電子部品や機械部品があり、患者の要求に応じてカスタマイズすることができます。心拍数が不規則になったり遅くなったりすることによって引き起こされる脳卒中や心不全などの合併症のリスクを軽減するのに役立ちます。このほか、心臓ペースメーカーは植え込み型除細動器や心臓再同期療法機器に組み込まれ、より包括的な治療アプローチを提供します。現在、主要企業は、患者が耐えやすく、外科医が植え込みやすいように、小型で侵襲性の低い心臓ペースメーカーを導入しています。

心臓ペースメーカーの市場動向：

心血管疾患（CVD）の有病率の増加は、世界中で心臓ペースメーカーの需要を牽引する大きな要因の一つです。さらに、不整脈、先天性心疾患、心房細動などの病気にかかりやすい高齢化人口の増加が市場の成長を後押ししています。加えて、健康意識の高まりと、心臓に関連する病気に対する利用可能な代替治療法についての認識が、市場にプラスの影響を与えています。これとは別に、心臓ペースメーカーに経済的支援を提供し、医療費を削減する健康保険に加入する人の増加が市場成長に寄与しています。さらに、主要企業は、より長い電池寿命と、ヘルスケア専門家がスマートフォンを使用して遠隔でデバイスの性能と患者の心機能を追跡できる遠隔監視機能を備えた心臓ペースメーカーを発売しています。主要企業はまた、ペースメーカー移植に伴う感染やその他の合併症のリスクを最小限に抑えるため、心臓ペースメーカーの製造に生体適合性材料を使用することに注力しています。これに加えて、心臓ペースメーカーにワイヤレス技術を統合し、デバイスとの間でデータを伝送することで、デバイスの精度と信頼性を向上させることができ、市場の成長を後押ししています。さらに、各国の行政機関は、手術技術を向上させ、医療施設へのアクセスを容易にするために、研究開発（R&D）活動に投資しています。

本レポートで扱う主な質問

  • 心臓ペースメーカーの市場の世界市場規模は？
  • 2025-2033年における世界の心臓ペースメーカーの市場の予想成長率は？
  • 世界の心臓ペースメーカーの市場を牽引する主要因は何か？
  • 世界の心臓ペースメーカーの市場に対するCOVID-19の影響は？
  • 世界の心臓ペースメーカーの市場のタイプ別内訳は？
  • 世界の心臓ペースメーカーの市場の技術別内訳は？
  • 世界の心臓ペースメーカーの市場の適応症別内訳は？
  • 世界の心臓ペースメーカーの市場のエンドユーザー別の内訳は？
  • 心臓ペースメーカーの市場の世界における主要地域は？
  • 世界の心臓ペースメーカーの市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の心臓ペースメーカー市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 埋込み
  • 外部

第7章 市場内訳：技術別

  • 両室
  • 単室
  • 二室
  • その他

第8章 市場内訳：適応症別

  • 不整脈
  • うっ血性心不全
  • その他

第9章 市場内訳：エンドユーザー別

  • 病院と診療所
  • 外来手術センター
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Biotronik
    • Boston Scientific Corporation
    • Lepu Medical Technology（Beijing）Co. Ltd.
    • MEDICO s.r.l.
    • Medtronic plc
    • MicroPort Scientific Corporation
    • Oscor Inc.（Integer Holdings Corporation）
    • Osypka Medical GmbH
    • Shree Pacetronix Ltd.
図表

List of Figures

  • Figure 1: Global: Cardiac Pacemaker Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Pacemaker Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cardiac Pacemaker Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Cardiac Pacemaker Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Cardiac Pacemaker Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Cardiac Pacemaker Market: Breakup by Indication (in %), 2024
  • Figure 7: Global: Cardiac Pacemaker Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Cardiac Pacemaker Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Cardiac Pacemaker (Implantable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Cardiac Pacemaker (Implantable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Cardiac Pacemaker (External) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Cardiac Pacemaker (External) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Cardiac Pacemaker (Biventricular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Cardiac Pacemaker (Biventricular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Cardiac Pacemaker (Single Chambered) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Cardiac Pacemaker (Single Chambered) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Cardiac Pacemaker (Dual Chambered) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Cardiac Pacemaker (Dual Chambered) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Cardiac Pacemaker (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Cardiac Pacemaker (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Cardiac Pacemaker (Arrhythmias) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Cardiac Pacemaker (Arrhythmias) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Cardiac Pacemaker (Congestive Heart Failure) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Cardiac Pacemaker (Congestive Heart Failure) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Cardiac Pacemaker (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Cardiac Pacemaker (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Cardiac Pacemaker (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Cardiac Pacemaker (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Cardiac Pacemaker (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Cardiac Pacemaker (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Cardiac Pacemaker (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Cardiac Pacemaker (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: North America: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: North America: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: United States: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: United States: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Canada: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Canada: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia-Pacific: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia-Pacific: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: China: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: China: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Japan: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Japan: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: India: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: India: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: South Korea: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: South Korea: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Australia: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Australia: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Indonesia: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Indonesia: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Europe: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Europe: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Germany: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Germany: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: France: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: France: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: United Kingdom: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: United Kingdom: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Italy: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Italy: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Spain: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Spain: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Russia: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Russia: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Latin America: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Latin America: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Brazil: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Brazil: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Mexico: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Mexico: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Middle East and Africa: Cardiac Pacemaker Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Middle East and Africa: Cardiac Pacemaker Market: Breakup by Country (in %), 2024
  • Figure 81: Middle East and Africa: Cardiac Pacemaker Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: Cardiac Pacemaker Industry: Drivers, Restraints, and Opportunities
  • Figure 83: Global: Cardiac Pacemaker Industry: Value Chain Analysis
  • Figure 84: Global: Cardiac Pacemaker Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiac Pacemaker Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Cardiac Pacemaker Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Cardiac Pacemaker Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Cardiac Pacemaker Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 5: Global: Cardiac Pacemaker Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Cardiac Pacemaker Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Cardiac Pacemaker Market: Competitive Structure
  • Table 8: Global: Cardiac Pacemaker Market: Key Players
目次
Product Code: SR112025A6873

The global cardiac pacemaker market size reached USD 5.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.0 Billion by 2033, exhibiting a growth rate (CAGR) of 3.29% during 2025-2033. The increasing prevalence of CVDs, rising number of people with health insurance policies, and extensive research and development (R&D) activities for improving surgical techniques represent some of the key factors driving the market.

A cardiac pacemaker is a small medical device implanted in the chest or abdomen to treat heart rhythm disorders using electrical pulses, which assist in regulating and monitoring the heartbeat. It has electronic and mechanical components, such as microprocessors, sensors, electrodes, wires, leads, and housing, and can be customized according to the requirements of the patient. It helps reduce the risk of complications like stroke and heart failure that can be caused by an irregular or slow heart rate. Besides this, a cardiac pacemaker is incorporated into implantable defibrillators and cardiac resynchronization therapy devices to offer a more comprehensive treatment approach. At present, key players are introducing small and less invasive cardiac pacemakers to make it easier for patients to tolerate and surgeons to implant.

Cardiac Pacemaker Market Trends:

The surging prevalence of cardiovascular diseases (CVDs) among the masses represents one of the major factors driving the demand for cardiac pacemakers around the world. Moreover, the rising aging population, which is more prone to ailments, such as arrhythmias, congenital heart disease, and atrial fibrillation, is favoring the market growth. In addition, the growing health consciousness and awareness about the available treatment alternatives for heart-related ailments are influencing the market positively. Apart from this, the increasing number of people with health insurance policies that provide financial assistance for cardiac pacemakers and reduce medical expenses is contributing to the market growth. Furthermore, leading players are launching cardiac pacemakers with longer battery life and remote monitoring capabilities that allow healthcare professionals to track the performance of the device and heart function of patients remotely using a smartphone. Key players are also focusing on using biocompatible materials in the manufacturing of cardiac pacemakers to minimize the risk of infection and other complications associated with pacemaker implantation. Besides this, the integration of wireless technology in cardiac pacemakers to transmit data to and from the device that can help improve the accuracy and reliability of the device is propelling the growth of the market. Additionally, governing agencies of numerous countries are investing in research and development (R&D) activities to improve surgical techniques and provide easy access to healthcare facilities.

Key Market Segmentation:

Type Insights:

  • Implantable
  • External

Technology Insights:

  • Biventricular
  • Single Chambered
  • Dual Chambered
  • Others

Indication Insights:

  • Arrhythmias
  • Congestive Heart Failure
  • Others

End User Insights:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for cardiac pacemaker. Some of the factors driving the North America cardiac pacemaker market included the growing incidences of cardiac disorders, rising geriatric population, the launch of MRI-compatible pacemakers and Bluetooth-enabled pacemakers, etc.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global cardiac pacemaker market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Lepu Medical Technology (Beijing)Co. Ltd., MEDICO s.r.l., Medtronic plc, MicroPort Scientific Corporation, Oscor Inc. (Integer Holdings Corporation), Osypka Medical GmbH., Shree Pacetronix Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.How big is the global cardiac pacemaker market?
  • 2.What is the expected growth rate of the global cardiac pacemaker market during 2025-2033?
  • 3.What are the key factors driving the global cardiac pacemaker market?
  • 4.What has been the impact of COVID-19 on the global cardiac pacemaker market?
  • 5.What is the breakup of the global cardiac pacemaker market based on the type?
  • 6.What is the breakup of the global cardiac pacemaker market based on the technology?
  • 7.What is the breakup of the global cardiac pacemaker market based on the indication?
  • 8.What is the breakup of the global cardiac pacemaker market based on the end user?
  • 9.What are the key regions in the global cardiac pacemaker market?
  • 10.Who are the key players/companies in the global cardiac pacemaker market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Pacemaker Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Implantable
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 External
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Biventricular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Single Chambered
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dual Chambered
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Arrhythmias
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Congestive Heart Failure
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgery Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Biotronik
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Boston Scientific Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Lepu Medical Technology (Beijing)Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 MEDICO s.r.l.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Medtronic plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 MicroPort Scientific Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Oscor Inc. (Integer Holdings Corporation)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Osypka Medical GmbH
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Shree Pacetronix Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.